Basic Information
Reyvow
0002-0632
Regulatory Information
0002-0632
August 21, 2020
REYVOW (lasmiditan) tablets, for oral use, [CV in USA] - FOR EXPORT ONLY Initial U.S. Approval: 2020
HUMAN PRESCRIPTION DRUG LABEL
2
Company Information
006421325
Active Ingredients
Inactive Ingredients
Microcrystalline cellulose
Code: OP1R32D61U
Class Code: IACT
Sodium Lauryl Sulfate
Code: 368GB5141J
Class Code: IACT
Croscarmellose Sodium
Code: M28OL1HH48
Class Code: IACT
Starch, corn
Code: O8232NY3SJ
Class Code: IACT
Magnesium Stearate
Code: 70097M6I30
Class Code: IACT
Polyvinyl Alcohol, Unspecified
Code: 532B59J990
Class Code: IACT
Titanium dioxide
Code: 15FIX9V2JP
Class Code: IACT
Ferric Oxide Red
Code: 1K09F3G675
Class Code: IACT
Talc
Code: 7SEV7J4R1U
Class Code: IACT
Polyethylene Glycol 3350
Code: G2M7P15E5P
Class Code: IACT
Ferrosoferric Oxide
Code: XM0M87F357
Class Code: IACT
Active Moieties
lasmiditan
Code: 760I9WM792